As of April 4^th^, 2020, the COVID-19 pandemic caused by the novel SARS-CoV-2 coronavirus^[@R1]^ has infected more than 1.2 million people worldwide and the rise in cases has been exponential. In particular, New York cases in the United States surged from 22 to more than 113,000 between March 10 and now^[@R2]^, threatening to overwhelm hospitals and other regional health care systems in the city.

In San Francisco, we validated a qRT-PCR test to detect SARS-CoV-2 infection from nasopharyngeal swab samples based on the EUA (Emergency Use Authorization)-approved US CDC assay^[@R3]^. During the first 10 days since launch, we performed SARSCoV-2 testing on 947 samples collected from March 10 through March 22 from patients with suspected SARS-CoV-2 infection at University of California, San Francisco. We analyzed the first 46 consecutive SARS-CoV-2 positive cases admitted to University of California, San Francisco hospitals or seen in outpatient clinics from March 10 through March 22. Data from these COVID-19 patients ([Table 1](#T1){ref-type="table"}) were matched with 102 randomly selected control patients over the same time period who tested negative for SARS-CoV-2. Documented history was recorded by a physician or nurse practitioner and included sick contacts, health care worker status, and travel history. Among the 46 COVID-19 patients, the median age was 44 years, 46% were female, and 65% were outpatients.

We noted that a travel history within 2 weeks of symptom onset (median date Mar 11, 2020) was significantly associated with COVID-19 infection (OR 3.8 \[1.8--8.4\]) ([Figure 1](#F1){ref-type="fig"}). Out of the 20 travelers with COVID-19 infection, there were significant associations for prior travel to Europe (5 travelers, OR 6.1 \[1.1--32.7\]), USA (14 travelers, OR 4.0 \[1.6--10.0\]), and specifically New York (6 travelers, OR 32.9 \[1.8--598\]) as compared to 17 travelers without COVID-19 infection ([Figure 2](#F2){ref-type="fig"} and [Table 2](#T2){ref-type="table"}). No significant associations were found with regards to close contacts with known COVID-19 infected persons or frontline healthcare workers. Of note was one cluster of 3 positive cases associated with COVID-19 infection in an airport worker, that was categorized as a case of community rather than travel-associated transmission.

Our evaluation of diagnosed COVID-19 cases in San Francisco in early March 2020 associates with travelers from New York prior to the recognized spike in New York cases in late March ([Figure 3](#F3){ref-type="fig"}). Travel from New York was underrecognized as a risk factor for COVID-19 infection in the United States in early March. Guidelines for COVID-19 testing have not included screening for domestic travel. Our findings in San Francisco here can be extrapolated across America as there are over 100 direct domestic destinations and more than 6 million domestic flights a month from JFK, Newark, and LaGuardia airports^[@R4]^. In the near future, serological testing would be needed for surveillance of the much larger population of individuals with mild illness or asymptomatic infection^5^.
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![Associations with Positive COVID-19 RT-PCR Testing.\
The odds ratios (OR) with 95% confidence intervals (CI) are displayed. Positives (n=46) were consecutive cases from March 10 to 20, 2020. Negatives (n=102) were randomized from the same time period. Significant risk factors (p \<0.05) are designated with '\*' and were recent travel, including Europe, USA (domestic), and/or New York. Abbreviations: Pos, positive; Neg, negative; OR, odds ratio; CI, confidence interval.](nihpp-2020.04.04.20053629-f0001){#F1}

![Travel History Associated with Positive Cases.\
All positive cases and their associations are shown here (left). Cases that overlapped in two categories (e.g. traveler and contact with a known positive, n=3) and were counted as a half-case in each category. Those who did not have recent travel history, close contact with a known COVID-19 positive, or a frontline healthcare worker, were uniformly categorized as a community case. The most common association with a positive case was a travel history immediately prior to symptoms. Travelers (n=20) are subdivided by travel region (right).](nihpp-2020.04.04.20053629-f0002){#F2}

![Timeline of cumulative COVID-19 cases diagnosed in New York, and UCSF positive cases found in San Francisco in association with New York or Europe over time.\
Each colored block represents a single patient.](nihpp-2020.04.04.20053629-f0003){#F3}

###### 

Clinical Characteristics of COVID-19 Positive Cases (n=46)

  ------------------------------- -------------
  Patient Demographics            
  Age -- years                    
   Median (interquartile range)   44 (33--62)
   Range                          (23--86)
  Gender                          
   Female -- no. (%)              21 (46%)
                                  
  ------------------------------- -------------

Abbreviations:

COPD - Chronic obstructive pulmonary disease

###### 

Risk Factor Associations with COVID-19 Infection

                                                 Odds Ratio \[CI 95%\]            P value
  ---------------------------------------------- -------------------------------- ------------
  Healthcare Worker                              0.8974 \[0.3442 to 2.3400\]      P = 0.8248
  Close Contact                                  2.8571 \[0.9684 to 8.4295\]      P = 0.0572
  Travel[\*](#TFN3){ref-type="table-fn"}         3.8462 \[1.7602 to 8.4043\]      P = 0.0007
  NYC/New York[\*](#TFN3){ref-type="table-fn"}   32.9012 \[1.8114 to 597.5961\]   P = 0.0182
  non-NY USA                                     1.3800 \[0.4695 to 4.0558\]      P = 0.5582
  Europe[\*](#TFN3){ref-type="table-fn"}         6.0976 \[1.1368 to 32.7054\]     P = 0.0349
  Asia                                           2.2444 \[0.1373 to 36.6894\]     P = 0.5706

Significant associations at a p-value of 0.05 for significance

###### 

Travel Locations by Patient History

  Infection Status               Geographic Location                        Count
  ------------------------------ ------------------------------------------ -------
  **COVID-19 Positive (n=29)**                                              
                                 New York metropolitan area or "New York"   5
                                 Not New York, but USA                      9
                                  • Colorado                                2
                                  • Chicago                                 1
                                  • Southern California (Los Angeles)       1
                                  • Idaho                                   1
                                  • Washington State                        1
                                  • Oregon                                  1
                                  • Hawaii                                  1
                                  • Washington DC                           1
                                 Europe                                     5
                                 Asia                                       1
  **COVID-19 Negative (n=25)**   New York metropolitan area or "New York"   5
                                 Not New York, but USA                      9
                                  • Washington State                        4
                                  • Georgia                                 2
                                  • Southern California                     2
                                  • Minnesota                               1
                                  • Texas                                   1
                                  • Hawaii                                  1
